{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:44:35Z","timestamp":1790477075873,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774332"],"award-info":[{"award-number":["81774332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873324"],"award-info":[{"award-number":["81873324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873325"],"award-info":[{"award-number":["81873325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objectives<\/jats:title>\n<jats:p>Autologous peripheral blood stem cell (auto-PBSC) transplantation is an effective therapeutic for the osteonecrosis of the femoral head (ONFH) but without prognosis estimation. This study mainly aimed to (1) determine whether auto-PBSC transplantation is a promising option, (2) assess the risk of hip-preservation failure, (3) achieve a predictive model of femoral head survival after the intervention, and (4) eventually identify clinical indications for auto-PBSC transplantation in future.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>After reviewing the in-patient database of the First Affiliated Hospital of Zhejiang Chinese Medicine University from June 2012 to June 2014, 37 eligible patients with Association Research Circulation Osseous stage I or II ONFH who were receiving intra-arterial infusion of auto-PBSCs were recruited. A case form was designed to retrieve relevant data. Hip-preservation failure was defined as the endpoint. All participants were stratified by the categorical risk of collapse, which was statistically tested through log-rank analysis. All significant factors were evaluated using Cox proportional hazards regression model, and a predictive nomogram plot was generated.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 47 hips were followed up for 53.96\u2009\u00b1\u200921.09\u2009months; the median survival time was 60.18\u2009months. Among the predictors, body mass index (BMI; <jats:italic>P<\/jats:italic>\u2009=\u20090.0015) and Harris hip score (HHS; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) independently affected femoral head survival. Patients with BMI\u2009\u2265\u200924\u2009kg\/m<jats:sup>2<\/jats:sup> exhibited a 2.58 times higher risk of hip-preservation failure [95% confidence interval (CI), 1.32\u20135.45] than those with BMI\u2009&lt;\u200924\u2009kg\/m<jats:sup>2<\/jats:sup>, whereas those with HHS\u2009\u2265\u200970 exhibited a 0.19 times lower risk (95% CI, 0.09\u20130.38) than those with HHS\u2009&lt;\u200970. Hazard ratios associated with age (<jats:italic>P<\/jats:italic>\u2009=\u20090.042), BMI (<jats:italic>P<\/jats:italic>\u2009=\u20090.012), HHS (<jats:italic>P<\/jats:italic>\u2009=\u20090.022), and necrotic volume (<jats:italic>P<\/jats:italic>\u2009=\u20090.000) were 1.038 (95% CI, 1.001\u20131.075), 1.379 (95% CI, 1.072\u20131.773), 0.961 (95% CI, 0.928\u20130.994), and 1.258 (95% CI, 1.120\u20131.412), respectively. A nomogram plot (score test <jats:italic>P<\/jats:italic>\u2009=\u20090.000; C-index\u2009=\u20090.8863) was available for the orthopedic doctor to predict hip survival probability.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The results suggest that intra-arterial infusion of auto-PBSCs prolongs femoral head survival. Age, BMI, HHS, and necrotic volume can influence the efficacy of this intervention.<\/jats:p>\n<jats:p>This study was approved by ethics committee of the trial center, number 2019-KL-075-01.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13287-020-01595-w","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T14:02:49Z","timestamp":1582725769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prognosis after autologous peripheral blood stem cell transplantation for osteonecrosis of the femoral head in the pre-collapse stage: a retrospective cohort study"],"prefix":"10.1186","volume":"11","author":[{"given":"Jiafei","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-4632","authenticated-orcid":false,"given":"Peijian","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"issue":"19","key":"1595_CR1","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2106\/JBJS.O.00071","volume":"97","author":"MA Mont","year":"2015","unstructured":"Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am. 2015;97(19):1604\u201327.","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"1595_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5312\/wjo.v6.i8.590","volume":"6","author":"J Moya-Angeler","year":"2015","unstructured":"Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthopedics. 2015;6(8):590\u2013601.","journal-title":"World J Orthopedics"},{"issue":"11 Suppl A","key":"1595_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1302\/0301-620X.95B11.32644","volume":"95-b","author":"K Issa","year":"2013","unstructured":"Issa K, Pivec R, Kapadia BH, Banerjee S, Mont MA. Osteonecrosis of the femoral head: the total hip replacement solution. Bone Joint J. 2013;95-b(11 Suppl A):46\u201350.","journal-title":"Bone Joint J"},{"issue":"Suppl 4","key":"1595_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2106\/JBJS.H.00671","volume":"90","author":"DR Marker","year":"2008","unstructured":"Marker DR, Seyler TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008;90(Suppl 4):175\u201387.","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"1595_CR5","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1016\/j.arth.2017.02.075","volume":"32","author":"NS Piuzzi","year":"2017","unstructured":"Piuzzi NS, Chahla J, Jiandong H, Chughtai M, LaPrade RF, Mont MA, et al. Analysis of cell therapies used in clinical trials for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplast. 2017;32(8):2612\u20138.","journal-title":"J Arthroplast"},{"issue":"3","key":"1595_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/jca.1021","volume":"16","author":"LM Knudsen","year":"2001","unstructured":"Knudsen LM, Nikolaisen K, Gaarsdal E, Johnsen HE. Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra-apheresis. J Clin Apher. 2001;16(3):114\u20139.","journal-title":"J Clin Apher"},{"issue":"4","key":"1595_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jbmr.2390","volume":"30","author":"Q Mao","year":"2015","unstructured":"Mao Q, Wang W, Xu T, Zhang S, Xiao L, Chen D, et al. Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial. J Bone Mineral Res. 2015;30(4):647\u201356.","journal-title":"J Bone Mineral Res"},{"issue":"10","key":"1595_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1302\/0301-620X.99B10.BJJ-2017-0233.R2","volume":"99-b","author":"M Chughtai","year":"2017","unstructured":"Chughtai M, Piuzzi NS, Khlopas A, Jones LC, Goodman SB, Mont MA. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Joint J. 2017;99-b(10):1267\u201379.","journal-title":"Bone Joint J"},{"issue":"1","key":"1595_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/stem.140106","volume":"14","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Bensinger WI. Optimization of peripheral blood stem cell mobilization. Stem Cells (Dayton, Ohio). 1996;14(1):106\u201316.","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"2","key":"1595_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ocl.2008.10.009","volume":"40","author":"V Gangji","year":"2009","unstructured":"Gangji V, Hauzeur JP. Cellular-based therapy for osteonecrosis. Orthop Clin North Am. 2009;40(2):213\u201321.","journal-title":"Orthop Clin North Am"},{"issue":"1","key":"1595_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13287-018-1018-7","volume":"9","author":"R Li","year":"2018","unstructured":"Li R, Lin QX, Liang XZ, Liu GB, Tang H, Wang Y, et al. Stem cell therapy for treating osteonecrosis of the femoral head: from clinical applications to related basic research. Stem Cell Res Ther. 2018;9(1):291.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1595_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4055\/cios.2016.8.1.1","volume":"8","author":"P Hernigou","year":"2016","unstructured":"Hernigou P, Trousselier M, Roubineau F, Bouthors C, Chevallier N, Rouard H, et al. Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress. Clin Orthopedic Surg. 2016;8(1):1\u20138.","journal-title":"Clin Orthopedic Surg"},{"issue":"5","key":"1595_CR13","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.transproceed.2010.02.077","volume":"42","author":"HJ Song","year":"2010","unstructured":"Song HJ. Peripheral blood stem cell transplantation for ischemic femoral head necrosis. Transplant Proc. 2010;42(5):1862\u20134.","journal-title":"Transplant Proc"},{"issue":"7","key":"1595_CR14","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00264-018-3787-0","volume":"42","author":"L Andriolo","year":"2018","unstructured":"Andriolo L, Merli G, Tobar C, Altamura SA, Kon E, Filardo G. Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis. Int Orthop. 2018;42(7):1689\u2013704.","journal-title":"Int Orthop"},{"issue":"12","key":"1595_CR15","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s10495-016-1292-8","volume":"21","author":"L Beer","year":"2016","unstructured":"Beer L, Mildner M, Gy\u00f6ngy\u00f6si M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair. Apoptosis. 2016;21(12):1336\u201353.","journal-title":"Apoptosis"},{"issue":"12","key":"1595_CR16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2106\/JBJS.I.00575","volume":"92","author":"MA Mont","year":"2010","unstructured":"Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92(12):2165\u201370.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"1595_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00264-013-1775-y","volume":"37","author":"JS Kang","year":"2013","unstructured":"Kang JS, Moon KH, Kwon DG, Shin BK, Woo MS. The natural history of asymptomatic osteonecrosis of the femoral head. Int Orthop. 2013;37(3):379\u201384.","journal-title":"Int Orthop"},{"issue":"1","key":"1595_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.arth.2018.09.005","volume":"34","author":"BH Yoon","year":"2019","unstructured":"Yoon BH, Jones LC, Chen CH, Cheng EY, Cui Q, Drescher W, et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 1: glucocorticoid-associated osteonecrosis. J Arthroplasty. 2019;34(1):163\u20138 e1.","journal-title":"J Arthroplasty"},{"issue":"1","key":"1595_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.arth.2018.09.006","volume":"34","author":"BH Yoon","year":"2019","unstructured":"Yoon BH, Jones LC, Chen CH, Cheng EY, Cui Q, Drescher W, et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 2: alcohol-associated osteonecrosis. J Arthroplasty. 2019;34(1):169\u201374 e1.","journal-title":"J Arthroplasty"},{"issue":"10","key":"1595_CR20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/bmt.2010.310","volume":"46","author":"HK Al-Ali","year":"2011","unstructured":"Al-Ali HK, Bourgeois M, Krahl R, Edel E, Leiblein S, Poenisch W, et al. The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2011;46(10):1296\u2013302.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"1595_CR21","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11999-013-2925-7","volume":"471","author":"MA Mont","year":"2013","unstructured":"Mont MA. CORR insights(R): does the extent of osteonecrosis affect the survival of hip resurfacing? Clin Orthop Relat Res. 2013;471(6):1935\u20136.","journal-title":"Clin Orthop Relat Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-01595-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:27:35Z","timestamp":1614212855000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01595-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01595-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the First Affiliated Hospital of Zhejiang Chinese Medicine University, number 2019-KL-075-01. All enrolled patients\u2019 written informed consents were obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}